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Although there is consensus that HPV integration is common in
invasive cervical carcinomas and uncommon or absent in low-
grade uterine cervical intraepithelial neoplasia (CIN I), estimates
for HPV integration in CIN II/III range from 5 to 100% using dif-
ferent PCR-based and in situ hybridization (ISH) approaches. It
has been suggested that HPV integration can be identiﬁed using
ISH by scoring of punctate signals. The increased sensitivity of ﬂu-
orescence ISH (FISH) methods, allowing the detection of single
copies of HPV, complicates the distinction between integrated and
episomal HPV. Recently it has been suggested that, in such assays,
the signals originating from integrated virus can be hidden in a
background of episomal HPV. We therefore compared 2 different
FISH protocols for the detection of integrated HPV in a series of
CIN II/III lesions: 1) a mild protocol in which episomal HPV and
RNA is retained and 2) a harsh protocol that extensively extracts
proteins and RNA, and which promotes the partial loss of episo-
mal HPV but not integrated HPV. A series of 28 HPV 16/18 posi-
tive CIN II/III lesions (17 solitary lesions and 11 lesions adjacent
to microinvasive carcinoma) were studied. A punctate signal pat-
tern was identiﬁed in 7 of these lesions with both protocols. Punc-
tate signal was also present in control samples from lesions that
are known to be associated with HPV integration (invasive squa-
mous cell carcinoma (n ¼ 3), adenocarcinoma in situ (n ¼ 3), and
invasive adenocarcinoma (n ¼ 1). HPV RNA contributed signiﬁ-
cantly to the intensity of punctate FISH signal, especially when
applying the mild protocol, as shown by omitting DNA denatura-
tion, including RNase pretreatment steps and measuring the ﬂuo-
rescence signal intensity. Also, HPV RNA was frequently detected
in addition to episomal/integrated HPV DNA in the majority of
the other 21 CIN II/III lesions; this resulted in intense granular/
diffuse FISH signals throughout the epithelium. However, in 7 of
these lesions, the harsh protocol gave a more consistent punctate
pattern in cells throughout the full thickness of the epithelium.
This supports the hypothesis that the harsh protocol unmasks inte-
grated HPV more efﬁciently by extracting RNA and episomal
HPV. Overall, with this harsh protocol, a clonally expanded popu-
lation of cells containing punctate HPV signals was found in 5 of
17 (29%) solitary CIN II/III lesions and in 9 of 11 (88%) CIN II/
III lesions associated with microinvasive carcinoma. Combining
these data with the results from our previous study, with the harsh
protocol in 7 of 40 (18%) solitary CIN II/III lesions and 19/21
(90%) CIN II/III lesions associated with microinvasive carcinoma
(p < 0.001), this pattern was found. This indicates that, when
robustly deﬁned, a punctate HPV pattern in CIN II/III lesions is
associated with the presence of an invasive carcinoma.
' 2005 Wiley-Liss, Inc.
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Several premalignant stages can be distinguished in the devel-
opment of carcinoma of the uterine cervix. These include cervical
intraepithelial neoplasia grades I, II and III (CIN I–III), also desig-
nated low-grade squamous intraepithelial lesions (LSIL, compris-
ing CIN I) and high grade SIL (HSIL, comprising CIN II-III).1–4
Nearly all invasive cervical carcinomas (ICCs) and CIN grade II/
III lesions contain human papillomavirus (HPV) DNA. Epidemio-
logical studies indicate that HPV is without doubt the most impor-
tant factor in the carcinogenic process of the uterine cervix. It has
been estimated that 80% of women acquire an HPV infection at
some point during their lifetime, but that the majority of these
infections are transient, with only a minority ever resulting in recog-
nizable CIN III. The vast majority of CIN I lesions regress sponta-
neously, and only very few lesions persist or progress to CIN II–III.
One factor considered to be of key importance for the progression
of intraepithelial lesions to invasive disease is integration of HPV
into the host cell genome.2,7–9 The majority of CIN II/III lesions
and all ICCs are infected with high risk (oncogenic) HPV types,
particularly HPV 16 and 18. The E2 region of the HPV genome,
which is involved in the regulation of the oncogenic HPV E6 and
E7 proteins, is frequently disrupted when the virus is inte-
grated.2,4,10,11 In the majority of cases this results in constant sup-
pression of key cell-cycle control proteins p53 and pRB by the
HPV E6 and E7 gene products, respectively. There is a consensus
that integration is common in ICC and most studies indicate that
integration is uncommon or absent in CIN I.
In reviewing the literature, Evans and Cooper12 commented on
the wide range of estimates for integration in CINII/III, i.e., 5 to
100% as determined by means of Southern blot assays, different
types of PCR analyses, as well as chromogenic and ﬂuorescence
in situ hybridization methods (FISH).13–18 They concluded that,
although questions remain regarding the prevalence of integration
in preinvasive lesions, ISH approaches may be a viable alternative
to PCR in determining both infection with high risk HPV as well
as its physical status.
The ﬁrst assays to detect integrated HPV were based on restric-
tion digestion/Southern blot hybridization.19 Comparison of ISH
signal patterns with these assays demonstrated that a punctate pat-
tern, consisting of 1 or a few discrete signal(s) in the nucleus, indi-
cates HPV integration into the cellular genome. A diffuse nuclear
pattern on the other hand represents multiple copies of episomal
HPV and correlates with viral replication.19 These early ISH
methods were based on moderately sensitive approaches but, in
the last decade, numerous more sensitive (F)ISH assays have
been developed that allow the detection of a single-copy of
HPV.17,20–24 Applying these sensitive methods to CIN II/III lesions
results, however, in an increase in the number of FISH signals
within individual nuclei. The inherent problem of this approach is
that signals originating from integrated HPV can be hidden in a
background of episomal copies. Furthermore, HPV can also be
present as concatamers, which makes the recognition of integrated
HPV even more difﬁcult.12 Moreover, HPV RNA can contribute to
the signals observed in these (F)ISH protocols.25,26
In our study, we determined the impact of different protocols
for the identiﬁcation of HPV by FISH with respect to signal distri-
bution throughout the epithelium, signal pattern (diffuse/punctate/
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granular) and contribution of HPV RNA to the ﬁnal hybridization
signal. For this purpose we compared a frequently used HPV
detection method that employs a mild pretreatment protocol to a
protocol that we developed for the visualization of chromosomal
targets.27,28 These chromosomal targets need harsh pretreatment
steps to open chromosomal sites for efﬁcient hybridization and
immunocytochemical detection. The latter protocol has been
shown to remove most of the cytoplasmic as well as nuclear pro-
teins and has been hypothesized to extract episomal HPV copies.12
Here we report that application of this protocol results in the par-
tial extraction of episomal HPV as well as HPV RNA, resulting in
better recognition of a punctate pattern indicative of integrated
HPV.
Materials and methods
Tissue material
Formalin-ﬁxed and parafﬁn wax-embedded endo/ectocervical
biopsies, diathermy loop excisions and cold knife cervical coniza-
tion samples were selected from the ﬁles of the Department of
Pathology, Foundation of Collaborating Hospitals of Eastern Gro-
ningen, Winschoten, The Netherlands. The cervical biopsies were
classiﬁed independently according to WHO criteria by 2 patholo-
gists (FS and CSH), after which all cases were reviewed together
and cases with discrepancy discussed until consensus was reached.
Invasion was classiﬁed according to FIGO staging criteria. Thirty-
two CIN II/III lesions were selected; 19 lesions showed no evi-
dence of an invasive carcinoma (consecutive cases of CIN II/III),
while 13 CIN III lesions were associated with a microinvasive car-
cinoma (consecutive cases of CIN II/III&mCA). The lesions were
processed in such a way that they were gathered on 3 slides. This
small tissue micro array allowed a comparison of hybridisation
results (quantiﬁed by measuring the ﬂuorescence intensity)
because all lesions were simultaneously processed including the
enzymatic (peroxidase) signal ampliﬁcation reaction. A small ser-
ies of controls was selected that were predicted to contain
integrated HPV; these included 3 squamous carcinomas, 1 adeno-
carcinoma and 3 adenocarcinomas in situ (ACIS). All ACIS were
HPV 18 positive: HPV DNA (notably HPV 18) is usually present
in the integrated form in endocervical neoplasia.29
Ki-67 and p16ink4a immunohistochemistry
Four micrometer thick tissue sections were dewaxed and
immuno stained as described previously. Brieﬂy, after deparafﬁni-
zation sections were pretreated with 0.3% H2O2 in methanol to
quench endogenous peroxidase activity, followed by antigen
retrieval using microwave heating at 1008C in 0.01 M citrate buf-
fer (pH 6.0) for 30 min (interval micro waving). The Ki-67
(Immunotech, Marseille, France) and p16ink4a (E6H4, DAKO A/S,
Denmark) were detected by incubating the slides subsequently
with the monoclonal antibodies (according to the instructions of
the supplier), biotinylated rabbit anti-mouse IgG (1:200, Vector
Laboratories, Burlingame, CA) and an avidin-biotinylated peroxi-
dase complex (ABC) (Vectastain PK4000, Vector Laboratories,
Burlingame, CA). Peroxidase activity was visualized using diami-
nobenzidine (DAB)/H2O2 and sections were counterstained with
haematoxylin and mounted in Entellan (Merck, Darmstadt,
Germany).
Fluorescence in situ hybridization
Probe selection and labeling procedures. Digoxigenin-labeled
HPV 16 and HPV 18 probes were purchased from PanPath,
Amsterdam, The Netherlands and used as a mixture (HPV 16/18)
for primary screening. Probes for chromosomes 1 (1q12),30 and 17
(17 alphoid centromere sequence)31 were selected to determine
hybridisation efﬁciency and reproducibility on chromosomal tar-
gets, and used to determine chromosomal aneusomy. The probes
were labeled by standard nick translation with biotin (Bio)- or
digoxigenin (Dig)-dUTPs. For multiple target analyses the follow-
ing probe combination was used: chrom 1-Bio and chrom 17-Dig.
Pretreatment protocols. Two different pretreatment protocols
were used. The mild procedure includes a simple pepsin incuba-
tion step in 0.2 N HCl combined with high temperature denatura-
tion.13 The harsh procedure includes 2 chemical (acid and protein
denaturation) soaking steps and a pepsin incubation step in 0.02 N
HCl.28,32 The sensitivity and reliability of the harsh protocol for
HPV was described previously by testing HPV positive cell lines
(SiHa, Hela and Caski) and screening of routine ﬁxed head and
neck lesions and cervical preneoplasia.17,21
Mild pretreatment. Four micrometer thick parafﬁn wax tissue
sections were dewaxed and digested with 8 mg/ml pepsin (800–
1,200 U/mg protein porcine stomach mucosa; Sigma Chemical Co.,
St. Louis, MO) in 0.2 M HCl for 10 min at 378C. The slides were
rinsed 3 times in H2O and dehydrated in an ascending ethanol
series. After air drying the HPV probe set was applied under a cov-
erslip (see below). Probe and target DNA were denatured simulta-
neously for 6 min at 908C prior to hybridisation. When target
denaturation was omitted, the probe was denatured separately in an
eppendorf tube for 10 min at 808C and chilled on ice prior to appli-
cation to the tissue section under a coverslip. For RNase treatment,
the slides were dewaxed and incubated for 10 min at 808C in 2 
SSC, rinsed in H2O at room temperature and dehydrated in an
ascending ethanol series. They were then incubated in 4 mg/ml
DNase free RNase (Roche, Mannheim, Germany) in 10 mM
TrisHCl, 1 mM EDTA pH 7.5 for 60 min at 378C.
Harsh pretreatment. Four micrometer thick parafﬁn wax tis-
sue sections were dewaxed, pre-treated with 85% formic acid/
0.3% H2O2 for 20 min at room temperature, and subsequently
dehydrated with 70% ethanol containing 0.01 M HCl (acid dehy-
dration), 90% ethanol and 100% ethanol for 3 min each prior to
air drying. The slides were incubated in 1 M NaSCN for 10 min at
808C, followed by acid dehydration and digestion with 4 mg/ml
pepsin (800–1,200 U/mg protein porcine stomach mucosa: from
Sigma Chemical Co., St. Louis, MO) in 0.02 M HCl for 15 min at
378C. The slides were rinsed 3 times in 0.01 M HCl and acid
dehydrated. After air drying sections were post-ﬁxed in 1% form-
aldehyde in PBS for 15 min at room temperature, rinsed 3 times in
PBS and dehydrated in an ascending ethanol series.
The chemical pretreatment steps (formic acid/hydrogen perox-
ide, and thiocyanate at 808C) in combination with pepsin treat-
ments remove nearly all nuclear and cytoplasmic proteins. This
procedure strongly improves the hybridisation efﬁciency, main-
tains nuclear morphology during the FISH procedure and reduces
the need for optimization of the digestion time for each sample.32
The chemical pretreatment steps in the harsh protocol lead to par-
tial denaturation of DNA (thiocyanate is a DNA denaturing
agent); application of this pretreatment step therefore does not
enable a valid evaluation of the contribution of RNA hybridization
when applying this pretreatment step.
The low level of autoﬂuorescence of cytoplasmic and nuclear
protein remnants after application of the harsh protocol indicates
that these proteins have been efﬁciently removed. In the mild pro-
tocol, nuclear and cytoplasmic autoﬂuorescence is frequently
greater, indicating that these proteins are at least partially retained.
In particular, the latter will have impact on the retention of RNA
in both cytoplasm and nucleus.
The probe sets were applied under a coverslip at a concentration
of 1 ng/ml in 60% formamide, 2  SSC, 10% dextran sulfate and
50  excess of carrier DNA (salmon sperm DNA). Probe and tar-
get DNA were denatured simultaneously for 5 min at 808C prior
to hybridization overnight at 378C. After hybridization the prepa-
rations were washed stringently in 50% formamide, 2  SSC at
428C (2 times 5 min) or 0.1  SSC at 618C (2 times 5 min).
Probe detection and microscopic imaging. The digoxigenin
(Dig)-labeled HPV probes were detected using the tyramide signal
ampliﬁcation (TSA) procedure as previously described for single
target hybridisation using rhodamine-labeled tyramide.33 In short,
the Dig-labeled probe was detected by peroxidase-conjugated
sheep anti-digoxigenin Fab fragments (SHaDIG-PO, 1:100; Roche
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Molecular Chemicals, Basel, Switzerland) or ﬁrst mouse anti-
digoxigenin (MaDig, 1:2,000 Sigma Chemical Co.), then a peroxi-
dase-conjugated rabbit anti-mouse (RaM-PO, 1:100 DAKO A/S
Glostrup, Denmark) and ﬁnally a peroxidase-conjugated swine
anti-rabbit (SwaR-PO, 1:100 DAKO) all for 30 min incubatoons at
378C, and washed in PBS/0.05% Tween-20. Thereafter, the TSA
ampliﬁcation reaction was carried out under a coverslip by apply-
ing 50 ml (1:500 diluted from a 1 mg/ml stock solution in ethanol)
rhodamine-labeled tyramide in PBS containing 0.1 M imidazole,
pH 7.6, and 0.001% H2O2 for 10 min at 378C. The slides were
washed in PBS containing 0.05% Tween-20 (Janssen Chimica,
Beerse, Belgium), dehydrated in an ascending ethanol series and
mounted in Vectashield (Vector Laboratories) containing 40,6-dia-
midino-2-phenylindole (DAPI; Sigma Chemical Co.: 0.5 ng/ml).
Comparison of conventional cytochemical detection systems and
TSA systems have shown that, especially with the latter system,
both speciﬁc and nonspeciﬁc (background) ISH signals may be
greatly ampliﬁed. It is essential to keep nonspeciﬁc probe binding
and detection at a minimum for routine application of the method.
Many parameters have been shown to have impact on the signal-to-
noise (S/N) ratio when applying the TSA method including, e.g.,
probe and detection conjugate concentration, type of tyramide,
ampliﬁcation buffer, reaction time and reaction temperature.34
The biotin (Bio) labeled centromeric probe was detected with
sequential incubations with ﬂuorescein isothiocyanate (FITC)
conjugated avidin (AvFITC, 1:100; Vector, Brunswig Chemie,
Amsterdam, The Netherlands), biotin conjugated goat anti-avidin
(BioGaA, 1:100 Vector Laboratories) and FITC-conjugated avidin
1:100, all for 20 min at 378C , diluted and washed in 4  SSC/
0.05% Tween-20 (Janssen Chimica, Beerse, Belgium). The follow-
ing series of incubations were used to detect the Dig-labeled centro-
meric probe: ﬁrst mouse anti-digoxigenin (MaDig, 1:2,000; Sigma
Chemical Co.), then rhodamine (TRITC) conjugated rabbit anti-
mouse (RaMTRITC, 1:1,000 Sigma Chemical Co.) and ﬁnally
TRITC-conjugated swine anti-rabbit (SwaRTRITC, 1:100 DAKO
A/S Glostrup, Denmark), all for 30 min at 378C, diluted and washed
in PBS/0.05% Tween-20. After detection, the slides were dehy-
drated in an ascending ethanol series and mounted in Vectashield
(Vector Laboratories) containing 40,6-diamidino-2-phenylindole
(DAPI; Sigma Chemical Co.: 0.5 ng/ml).
Imaging. Images were recorded with the Metasystems Image
Pro System (black and white CCD camera; Sandhausen, Germany)
mounted on a Leica DM-RE ﬂuorescence microscope equipped
with FITC, TRITC, DAPI and SpectrumGold single bandpass ﬁl-
ters for single color analysis and a triple bandpass ﬁlter set (FITC,
TRITC and DAPI) for simultaneous dual- and triple-color analy-
sis. Images were recorded using an automatic integration time
allowing quantitative measurements (using the full dynamic range
of the camera without signal intensity saturation; TIF 8 bits
image). Furthermore, ﬁxed integration times were used to compare
ﬂuorescence intensity between different preparations.35 FISH ﬂuo-
rescence was measured per area or per individual nucleus using
Image/J (http://www.nih.gov, public domain), after color separa-
tion (RGB split), thresholding and selection of regions of interest.
TABLE I – SUMMARY OF SEMI-QUANTITIVE EVALUATION OF IN SITU HPV SIGNALS USING A X40 DRY OBJECTIVE1
Group Case Age CIN lesion HPV tested
Staining patterns
mild protocol harsh protocol
Diffuse Granular Punctate Diffuse Granular Punctate
A 1 38 III 16/18 n 
2 32 III&mCA 16/18 n &
3 36 III 16/18 n n &
4 24 III 16/18 n n 
5 29 III 16/18 n n &
6 28 III 16/18 n n  
7 35 III 16/18 n n n
8 41 III 16/18 n n 
9 37 III 16/18 n n n 
10 31 II 16/18 n 
11 22 III 16/18 n & &
12 34 II/III 16/18 n n
13 31 III 16/18 n & 
14 36 II&mCA 16/18 n &
B 15 38 III&mCA 16/18 n & & &
16 34 III&mCA 16/18 n 
17 41 III&mCA 16/18 n n 
18 n.a III 16/18 n n n n
19 40 III&mCA 16/18  n & 
20 39 III 16/18 n 
21 47 III&mCA 16/18 n 
C 22 30 III 16/18 n n  n 
23 38 III&mCA 16/18 n  
24 43 III&mCA 16/18  n
25 37 III 16/18 n 
26 30 III 16/18 n 
27 48 III&mCA 16/18 n n
28 30 III&mCA 16/18 n n
29 35 squam. CARC 16/18 n n
30 n.a squam. CARC 16/18 n.d. n
31 n.a squam. CARC 16/18 n.d. n
32 35 ACIS 18 n 
33 n.a ACIS 18 n.d. n
34 32 ACIS 18 n.d. n
35 40 adeno CARC 18 n 
1Highest intensity indicated by n, intermediate intensity by , and lowest intensity by&. The criteria for assessment of signal type are given
in Material and methods. n.a: not available, n.d: not done.
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FIGURE 1.
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Signal intensity (spot or nucleus) was calculated as mean signal
intensity (per pixel) times area.
To compare the impact of the different protocols and/or pre-
treatment steps on FISH signal distribution throughout the epithe-
lium, only samples that were processed simultaneously were
compared. Furthermore lesions were collected on small tissue
arrays that enabled identical processing of different lesions.
Controls and evaluation of FISH results. Controls included
HPV-16 and -18 hybridization on tissue sections of formalin ﬁxed
and parafﬁn wax-embedded HPV positive cell lines (SiHa, CaSki
and HeLa). Evaluation of nuclear hybridization signals was per-
formed by 3 investigators (A.H., M.K. and C.H). Signal morphol-
ogy was categorized as follows: 1) When nuclei were completely
and homogeneously stained, the signal was classiﬁed as diffuse.
Often, the other nuclei exhibited multiple ﬂuorescent signals with
variation in spot number between individual cells within the
lesion; 2) When nuclear signals varied signiﬁcantly in size and
intensity this pattern was termed granular13 and 3) Discrete
nuclear signals (1–3 per nucleus) in a clean background were clas-
siﬁed as punctate, in line with the criteria of Cooper et al.19
The method was tested on 4 mm thick formalin ﬁxed and paraf-
ﬁn wax-embedded CaSki and SiHa cell lines that contain appr-
oximately 500 and 2 copies of integrated HPV 16, respectively.17
The FISH procedure as described above, guarantees an optimal
signal-to-noise ratio.17,33,36 In particular with the ﬂuorescent TSA
method, noise is often present as a result of background reactions
which could be misclassiﬁed as viral particles. Histological HPV
negative areas (e.g., lymphocytes) served as internal controls to
estimate speciﬁc and nonspeciﬁc signal.
Results
Ki-67 and p16INK4a immunohistochemistry
The Ki-67 index was mainly utilized for veriﬁcation of the dif-
ferent histological entities and served as a landmark in brightﬁeld
microscopy to guide evaluation of the FISH patterns. All cervical
lesions positive for p16INK4a exhibited strong nuclear and cyto-
plasmic immuno staining in the premalignant areas. FISH HPV-
positivity correlated strongly with p16INK4a accumulation, but not
all p16INK4a positive cells showed a FISH signal for HPV 16/18
DNA.
Distribution of HPV 16/18 FISH signals in (pre)malignant lesions
The results of the HPV FISH reactions for the 2 protocols are
summarized in Table I, and typical examples are depicted in
Figure 1. In total, 32 high grade CIN II/III lesions were examined
for the FISH distribution patterns of HPV after applying the 2 dif-
ferent protocols. HPV 16/18 positivity was detected in 17 CIN II/
III lesions and in 11 CIN II/III lesions adjacent to microinvasive
carcinomas. Four lesions were HPV 16/18 FISH negative (in both
protocols) and most likely contain other HPV types (not deter-
mined). In the control group, cases were compared after applying
the 2 different protocols.
The results were obtained by visual evaluation of the FISH sig-
nal intensity. No imaging by means of the CCD camera was
needed for this classiﬁcation. Intensity differences obtained for
both protocols were compared for individual lesions within identi-
cal areas on serial sections. The absolute ﬂuorescence intensity of
the signals varied within a relatively wide range between individ-
ual lesions, which results in a range of capture times (automated
integration time, range 0.1–3 sec, average about 0.3 sec) using the
CCD camera for imaging. This variation does not inﬂuence the
classiﬁcation upon visual inspection.
In general the mild protocol resulted in HPV signals of higher
ﬂuorescence intensity than the harsh protocol. The lesions were
grouped according to the major types of HPV distribution pattern.
In lesions 1–14 (group A), only diffuse and/or granular patterns
were recognized when applying both pretreatment protocols. In
lesions 15–21 (group B), the patterns obtained with the 2 protocols
were clearly discordant. Only punctate patterns were recognized
with the harsh protocol, while the mild protocol showed a granular
pattern in all cases. In half of these cases, this granular pattern was
combined with a diffuse pattern. In cases 22–35 (group C), the
majority of the lesions showed the typical punctate pattern with
both protocols.
Cases 1–14 (group A). In this group, the nuclei with a diffuse
pattern were predominantly found in the superﬁcial layers. A dif-
fuse pattern is illustrated for the mild and harsh protocol in Figure
1b,c (case 2). In this case, strongly ﬂuorescent signals were
present in individual cells of the basal part of the epithelium with
the mild protocol (compare Fig. 1e,g). In Figure 1b,c, these signals
in the lower compartment cannot be seen because of their small
size, which is below the resolution of this image. A typical diffuse
and granular pattern from this group after application of the mild
protocol is depicted in Figure 1j.
In this group, a similar pattern was obtained using both meth-
ods. Overall the HPV FISH signal intensities for the mild protocol
were higher in these lesions than the signals obtained with the
harsh protocol in 11 of 14 cases. Quantitative measurements of the
ﬂuorescence intensity in nuclei in the superﬁcial layer of case 2
revealed about 30-fold higher signal intensity compared to the
basal/parabasal cell nuclei (Fig. 2a). This difference is attributed
to viral replication in superﬁcial layers and low viral copy number
in the basal/parabasal layers. The intensity obtained with the harsh
protocol in the superﬁcial layers of this case was 15-fold lower
than the intensity measured for the mild protocol.
These differences in signal intensity support the hypothesis that
the harsh protocol leads to removal of episomal HPV copies as a
result of the more aggressive removal of cytoplasmic and nuclear
constituents. Moreover, the contribution of HPV RNA hybridiza-
tion to the signal might be considerable and this was studied by
omission of target DNA denaturation and by application of RNase
digestion followed by DNA denaturation. When denaturation of
the target DNA was omitted, resulting in the detection of only
RNA, strong signals were seen in the lower compartment of the
epithelium (Fig. 1e). A surface plot of the ﬂuorescence intensity in
the lower part of the epithelium (Fig. 1f) illustrates the high inten-
sity of these signals in a relatively low background. We conclude
that these signals originate from RNA because the signals disap-
peared when an RNase pretreatment step was included in the pro-
tocol (results not shown). However, if a denaturation step was
included after RNase pretreatment, these areas exhibited multiple
small signals, representing HPV DNA (Fig. 1g). The number of
HPV DNA spots per nucleus increases towards the more superﬁ-
FIGURE 1 – Representative examples of tissue sections from
patients diagnosed with cervical intraepithelial neoplasia stained with
haematoxylin (a,i,o), analyzed by FISH for oncogenic type HPV 16/
18 shown in green (b,c,e,g,j,k,m,n,p,q), a double target hybridization
on chromosomes 1 and 17 (d) and immunohistochemical staining for
p16ink4a (i). (a-h) (case 2): HPV analysis of a CIN II/III lesion with
the mild protocol (b) and the harsh protocol (c). (e) and (g) Results
obtained with the mild protocol without DNA denaturation (e) or with
RNase treatment prior to DNA denaturation (g). (d) Double target
hybridization on chromosomes 1 and 17 developed in green (FITC)
and red (TRITC) ﬂuorescence, respectively. Nuclear counterstaining
in FISH experiments was with DAPI (blue). (f,h) Surface ﬂuorescence
intensity plots of (e) and (g), respectively. These plots illustrate the
high level of signal to noise ratio and distribution of the spots within
the individual nuclei. (i–k) (case19): CIN III lesion analyzed with the
mild protocol (j) and the harsh protocol (k). In the mild protocol, there
are superimposed signals apparently originating from HPV RNA and/
or episomal HPV.( l–n) (case 26): CIN III lesion immunohistochemi-
cal staining for p16ink4a (i) and HPV detection using the mild protocol
either by omitting DNA denaturation (m) or RNase treatment followed
by a target denaturation (n). (o–q) (case 28): CIN III area
(CINIII&mCA) analyzed with the mild protocol (p) or the harsh proto-
col (q). Higher magniﬁcations (inserts) show nuclei with 1 strong and
1 weak HPV signal in both protocols.
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cial layers of the epithelium and so does the ﬂuorescence intensity
per individual nucleus (Fig. 1h). The majority of the other lesions
did not show the clear-cut diffuse pattern in the superﬁcial layer.
Utilizing the mild protocol, a granular pattern was often seen in
these cases, signals being frequently heterogeneous in size and
intensity (Fig, 1j). Sometimes these granular patterns were local-
ized to the lower compartment of the epithelium, but in other cases
they were scattered throughout the whole of the epithelium. This
granular pattern correlated with RNA synthesis as shown by omis-
sion of DNA denaturation or by including the RNAse digestion
step. Further analysis demonstrated that these RNA signals were
superimposed onto multiple spots of HPV DNA. These ﬁndings
indicate that, in these cases, the contribution of HPV RNA to sig-
nal intensity is considerable with the mild protocol. The same
holds true for the retention of episomal copies of HPV in the mild
protocol.
Cases 15–21 (group B). In this group, we recognized with the
harsh protocol a punctate pattern that extended from basal to
superﬁcial layers. Figure 1k shows an example of the results with
the harsh protocol, with the number of signals per nucleus varying
within a small range (mean 1.3) and with a single discrete signal
throughout the entire thickness of the epithelium in 80% of the
nuclei. The mild protocol resulted in a more granular/diffuse pat-
tern with very heterogeneous staining throughout the epithelium
(see Fig. 1j). In these nuclei, the number of signals varied over a
wide range (1 to >10, mean 4). Quantiﬁcation of the ﬂuorescence
intensity showed that the intensity of the individual spots in both
methods was of comparable intensity and showed no signiﬁcant
difference in average intensity (Fig. 2b). The distribution of the
intensities of ﬂuorescent HPV signals measured in a high power
ﬁeld is plotted, with the signals being ranked according to increas-
ing ﬂuorescence intensity. More signals can be identiﬁed using the
mild protocol, but the average intensity per signal differed only
slightly when comparing the mild with the harsh protocol, i.e.,
5,000 vs. 4,500 a.u., respectively.
The contribution of HPV RNA hybridization to the signal
was considerable in this group. This resulted in a granular
pattern that was seen throughout the epithelial lesion but in
none of these cases did positive cells extend from basal to
superﬁcial layer. Sometimes several layers within the epithelium
showed strong nuclear RNA signals, while in others the distri-
bution was more random.
FIGURE 2 – Quantitative ﬂuorescence measurements of FISH signals. Fluorescence signal intensity per individual nucleus or FISH signals is
measured per high power ﬁeld (400)and ranked according to increasing ﬂuorescence signal intensity. For measurements of ﬂuorescence inten-
sity see Material and methods. (a) Histograms illustrating HPV integrated ﬂuorescence (IF, arbitrary units) in selected nuclei present in basal/
parabasal and superﬁcial cell layers processed following either the mild or the harsh protocol (case 2). For representative high power ﬁelds, in
which the IF was measured, see Figure 1b (capture time 0.2 sec) and 1c (capture time 3 sec) for the mild and harsh pretreatment methods,
respectively. (b) Plot for HPV hybridization signals using the mild and harsh protocols in 2 corresponding areas of serial tissue sections (case
19). For representative high power ﬁelds, in which the ﬂuorescence signal intensity was measured, see Figure 1j and k for the mild and harsh pre-
treatment methods, respectively. (c) Plot for HPV hybridization signals in 2 corresponding areas in serial tissue sections pretreated with the mild
and harsh protocol exhibiting a typical punctate pattern (case 28). Many nuclei exhibited 2 discrete punctate signals, 1 large and 1 small ﬂuores-
cent signal. For representative high power ﬁeld, in which the signals were measured, see ﬁgures 1p and q for the mild and harsh pretreatment
methods, respectively. (d) Plot for centromere repeat sequence (1q12) hybridization spots in 2 lesions, within 2 different high power ﬁelds (case
2: area 1 and 2, case 28: area 3 and 4). For a representative high power ﬁeld, in which the signals were measured, see Figure 1d.
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Cases 22–35 (group C). Typical examples of cases with punc-
tate HPV FISH patterns are shown in Figure 1m,n. These images
are illustrative for the majority of lesions in which both the mild
and the harsh protocol resulted in a punctate pattern. In all these
lesions, the positive cells were found throughout the entire thick-
ness of the epithelium (basal to superﬁcial) or occasionally as
small homogeneous foci. In 11 of 14 lesions that exhibited a punc-
tate pattern, only 1 HPV signal was seen in each nucleus. In case
28 the nuclei contained additional small FISH signals (1 or 2) next
to 1 strong signal in all nuclei throughout the full epithelial layer
(see inserts Figure 1p,q).
The contribution of RNA to the HPV signal is more easily
assessed in this group than in the lesions in groups A and B
because these lesions exhibited a discrete single FISH signal. Case
26 exhibited 1 strong FISH signal per nucleus with the mild proto-
col (not shown). Omitting target denaturation resulted in intense
staining as depicted in Figure 1m. After RNase treatment and
simultaneous denaturation, 1 signal per nucleus was left (Fig. 1n)
but with a signiﬁcantly lower intensity than without RNase treat-
ment. In this case, approximately 80% of the signal intensity stems
from hybridization to RNA. In 3 squamous lesions (cases 25, 26
and 32) and 1 adenocarcinoma (case 35), RNA contributed signiﬁ-
cantly to the ﬁnal signal using the mild procedure, again up to
80%. In these cases the mild protocol produced higher signal
intensity than the harsh protocol. It is noteworthy that 3 of these 4
lesions were HPV 18 positive. In the other cases, the difference
was not so evident.
In Figure 2c (case 28), quantiﬁcation of the ﬂuorescence inten-
sity showed that the intensities in both methods are comparable,
about 280 and 390, respectively. It is difﬁcult to conclude that the
somewhat higher intensity using the mild protocol is the direct
effect of hybridization to RNA since hybridization to integrated
HPV DNA will contribute to the hybridization signal.
Overal we found that RNA contributes signiﬁcantly to the
hybridization signal obtained with the mild protocol and that the
harsh protocol removes RNA as a result of the aggressive extrac-
tion of nuclear constituents.
Efﬁciency of chromosomal (DNA) target detection
To show that the harsh protocol does not inﬂuence the efﬁ-
ciency of chromosomal target detection, we applied both the mild
and the harsh protocol for the detection of chromosome centro-
meric DNA targets. For this we hybridized DNA centromeric
probes to all of the lesions (for example, see Fig. 1d) and used the
variation in signal intensity between the different lesions as an
indicator of the efﬁcacy of both protocols. Comparable reactivity
was seen in all lesions with the harsh protocol, with nearly all
nuclei reactive and showing strong FISH signals. The autoﬂuores-
cent background was low, which is an indicator of the efﬁcient
removal of proteins from the cytoplasm and nucleus. These
experiments conﬁrmed that the harsh protocol in principle is an
efﬁcient method to open chromososomal sites. The mild protocol
on the other hand was suboptimal for hybridization to chromoso-
mal targets since a comparable intensity to that obtained with the
harsh protocol was identiﬁed in only about 25% of cases. In the
other lesions, the reactivity was strongly variable throughout the
lesion and many lesions showed a high level of autoﬂuorescence.
Two lesions were analyzed in detail by measuring the intensity
of individual signals. One case was known to show a typical dif-
fuse HPV pattern while the other showed a punctate HPV pattern.
About 700 chromosomal centromere FISH signal intensities were
measured and the average intensity was not signiﬁcantly different
in these 2 lesions (see Fig. 2d).
Frequency of punctate signal pattern in CIN II/III with
and without an adjacent microinvasive carcinoma
Although the study was not intended to determine the frequency
of a punctate signal pattern in CIN II/III and CIN II/III adjacent to
a microinvasive carcinoma, we describe these results here because
they add value to our earlier report.17 In the previous study, 45
other cases were studied using only the harsh protocol. In the
present study a punctate pattern was found in 5 of 17 (29%) soli-
tary CIN II/III lesions and in 9 of 11 (82%) lesions with an adja-
cent microinvasive carcinoma. This shows that the punctate
pattern, which is assumed to be an indication of integration of the
virus into the genome, correlates strongly with the transition of a
premalignant lesion to microinvasive carcinoma (p < 0.01). The
mild protocol did not discriminate since a punctate pattern was
found in 3 of 17 (17%) CIN II/III lesions and 4 of 11 (36%)
CIN&mCA.
When the data from our previous study are included, a punctate
pattern was seen in 7 of 40 (18%) CIN II/III lesions and in 19 of
21 (90%) CIN&mCA lesions (p < 0.001).
Discussion
In our study, we determined the impact of 2 protocols on the
recognition of punctate signal pattern by FISH. It is generally
accepted that diffuse signals that represent (replicating) episomal
HPV can be distinguished from (strong) punctate signals that indi-
cate integrated HPV. The diffuse pattern is found commonly in
low grade intraepithelial lesions and the punctate pattern is charac-
teristically present in invasive carcinomas. However, more com-
plex patterns are found in lesions of intermediate grade (CIN II/
III) since the associated HPV infections are generally abortive and
the full life cycle of the virus is not supported.2,9 Furthermore the
sensitive tyramide ampliﬁcation methods that allow the detection
of single copy HPV particles complicate these patterns. In addition
to describing the morphological patterns of HPV FISH signal
obtained with tyramide signal ampliﬁcation systems, our study
quantiﬁed HPV signals for the ﬁrst time in different types of high
grade CIN lesions and in invasive carcinomas and determined the
contribution of HPV RNA hybridization to signal intensity, as
well as intensity variations within single nuclei/cells throughout
the epithelium. Two different protocols for HPV detection were
used: a mild protocol that retained episomal viral copies and RNA
more efﬁciently, and a harsh protocol that was hypothesized to
remove protein and RNA extensively and to partly extract episo-
mal HPV copies.
This comparison allowed us 1) to assess the contribution
of RNA hybridization to FISH signal intensity and 2) to identify
clonally expanded cells harboring a punctate signal (indicative
of HPV integration) present throughout the thickness of the
epithelium.
Impact of RNA hybridization on HPV signal
The contribution of RNA hybridisation to HPV signal was best
illustrated in the cases that exhibited a punctate pattern. In particu-
lar, in those lesions where HPV is known to be integrated, as is
the case in ACIS and adenocarcinomas, it was noticed that, using
the mild protocol, hybridization to HPV RNA was the major con-
tributor to the HPV signal. That this RNA was extracted by the
harsh protocol was deduced from experiments on these lesions
because the signal intensity for the harsh protocol was comparable
with the mild protocol in which RNase treatment had been per-
formed prior to denaturation. In these cases, it cannot be excluded
that the harsh protocol detects only integrated HPV DNA, while,
in the mild protocol, residual RNA is the major target for hybrid-
ization. This is because many reports have shown that additional
steps are needed in combination with the mild protocol to open
chromosomal sites for efﬁcient hybridization and immunocyto-
chemical detection.37 So, loss of hybridization efﬁciency on DNA
could be compensated for by hybridization to RNA when the mild
protocol is used. The strong RNA signal is consistent with appa-
rent disruption of the E2 gene, resulting in unregulated overex-
pression of viral E6 and E7 gene products, although this cannot be
determined with certainty as we used a total HPV DNA probe.9
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When analyzed using the mild procedure, the majority of CIN
II/III lesions exhibited a mixed diffuse/granular pattern and RNA
also contributed signiﬁcantly to the signal intensity. This resulted
in patterns that were best described as granular. The RNA signals
were superimposed on multiple small HPV DNA signals: these
RNA patterns were inhomogeneous throughout the lesion and
were predominantly seen as punctate signals in the lower compart-
ment of the epithelium. This is consistent with the synthesis of E6
and E7 in this part of the epithelium.9 Whether or not these pat-
terns represent cells in which the virus is integrated can not be
determined by FISH12. We can argue either that this indicates
integration, although the scattered distribution pattern of these
cells is not indicative of clonal outgrowth, or that, in these cells,
there is temporary upregulation of RNA synthesis.
Impact of episomal HPV on the recognition of integrated HPV
With respect to the signal patterns, our study, when applying the
mild protocol, conﬁrms the ﬁndings of Evans et al.13 who applied
the mild protocol in combination with a sensitive bright ﬁeld TSA
ISH method. They observed small punctate signals throughout all
epithelial layers in nearly all CIN III lesions. In most cases this
was combined with a diffuse pattern.
Quantiﬁcation of the FISH signals in our study showed that,
although the patterns were the same in both protocols, the signal
intensity in the mild protocol was frequently higher compared to
the signal intensities obtained with the harsh protocol. In the
lesions with a punctate pattern (group C), this could be attributed
to the contribution of RNA (see above). In the other groups of
lesions (group A and B), this difference can be ascribed to both
extraction of RNA and partial loss of episomal copies in the harsh
protocol. It could be argued that this difference can be entirely
attributed to RNA hybridisation. However, the observations that
1) after denaturation of a RNase-treated lesion, analyzed using the
mild protocol, the intensity was still higher compared to the harsh
protocol and 2) chromosomal targets are more efﬁciently hybri-
dized in the harsh protocol than in the mild protocol, indicating
that integrated HPV is unlikely to have been lost in the harsh pro-
tocol, argue in our opinion for loss of episomal copies in the harsh
protocol. This partial loss of episomal copies is however very dif-
ﬁcult to measure because we do not know how many copies per
cell are present within the lesion and we have no denominator for
the effectiveness of removal of episomal copies. Furthermore, the
presence of concatamers of HPV (with a high molecular weight)
in these cells, which are likely to be more strongly anchored in the
nucleus, complicates this estimation. Evans et al.12 interpreted the
punctate signals as integration in all CIN 11/III lesions. Although
they emphasize that not all signals represent integrated HPV, all
the lesions were classiﬁed as HPV integrated lesions. This implies
that, in nearly all CIN III lesions, the integrated HPV is hidden in
a background of episomal copies.
Our data suggest that this shielding of integrated HPV does
occur. However, this was only seen in 7 of 21 CIN II/III lesions
and was identiﬁed when the lesions were processed following the
harsh protocol: the mild protocol was inconclusive in these cases.
Furthermore the fact that the punctate pattern was seen throughout
the full thickness of the epithelium in these lesions strengthens the
assumption that these cells have undergone clonal expansion. It
was surprising to see that 5 of these lesions were associated with a
microinvasive carcinoma.
One could argue that it is unlikely that these signals represent
integrated HPV because more prominent expression of RNA
should have been identiﬁed in these cases and that this should
have resulted, in particular using the mild protocol, in strong punc-
tate signals (as discussed above). A possible explanation for the
reduced expression could be that RNA expression is variable or
that detection is affected by methodological issues such as, e.g.,
tissue ﬁxation and reproducibility of the pretreatment. An alterna-
tive explanation is that the E2 gene is still intact, suppressing E6/
E7 transcription, or that E2 synthesized from episomal copies sup-
presses the E6/E7 from integrated virus.38 The latter has been
demonstrated by transfection of E2 into cell lines containing inte-
grated HPV.
Frequency of integration in CIN II/III
In a previous study, we found that the punctate signal pattern,
and by implication integration of HPV, in CIN II/III lesions, as
assessed by FISH, correlated with the presence of a microinvasive
carcinoma (p < 0.001)17. Although the present study was not
designed to validate this observation further, the same signiﬁcant
correlation was found (p < 0.01) when utilizing the harsh protocol
in the newly selected cases. Combining the data from both studies,
7 of 40 (18%) solitary CIN II/III lesions showed a clonally
expanded population of cells containing integrated HPV. In the
series of CIN III lesions adjacent to a microinvasive carcinoma,
integration dominated and was shown in 9 of 11 cases. Consistent
with these ﬁndings, several earlier studies state that integration of
HPV, detected by PCR or FISH, occurs preferentially in associa-
tion with invasion and is relatively uncommon in noninvasive
intraepithelial neoplasms.19,39,40
Recently Wentzensen et al.39–43 reviewed the genomic integra-
tion sites of HPV in epithelial dysplasia and invasive cancer as
determined by means of direct HPV DNA integration methods as
well as the ampliﬁcation of papillomavirus oncogene transcripts
(APOT) assay. By means of these assays, a total of 192 individual
HPV integration sites have been reported; approximately 180 of
these sites were determined in invasive carcinomas, while the site
of HPV integration was determine in only 10 CIN III lesions. In
these CIN III lesions, the APOT assay was used in combination
with an extensive comparative database search to identify the
genomic location. In these cases, there is direct (biochemical)
proof of integration into the genome determined by the presence
of a RNA fusion product. Our observation that the cells with a
punctate pattern (after application of the harsh protocol) are
present throughout the whole epithelial layer supports the view
that cervical epithelia expressing chromosomally integrated HPV
oncogenes have a strong selective growth advantage.41,44
The frequency at which these punctate staining patterns are
detected in our study in solitary CIN II/III is in line with the data
(frequencies) obtained by the group of von Knebel Doeberitz,40,45
who detected integration of HPV by means of PCR ampliﬁcation
of viral transcripts (APOT assay: 4.5–5% CIN II; 14–15.6% CIN
III) and Kalantari et al.39 who applied an inverse polymerase chain
reaction (5% CIN III, rliPCR) assay. These studies point to the
marked difference between the prevalence of integration in CIN
II/III lesions and invasive carcinomas, and conﬁrm the data
obtained using Southern blot analysis.46.
In contrast, several other studies report that viral integration is
common in CIN II/III. By use of a PCR protocol, measuring E2/
E6 DNA ratio, Peitsaro et al.47 measured ratios between episomal/
integrated HPV copies of about 1.0 (or lower) in nearly all CIN II/
III lesions. There is no obvious methodological reason for the dis-
crepancy between these data and those obtained using APOT and
rliPCR, although, e.g., choice of primer, length of amplicon and
quality of material (frozen vs. parafﬁn embedded material) will
inﬂuence the efﬁciency of the assay. The duration of the disease,
and hence the frequency of integration, may also be different in
various studies. Furthermore, in HPV DNA concatamers, E2 DNA
sequences could be lost, while no RNA is synthesized. The latter
would result in an apparent discrepancy because loss of E2 would
lead to classiﬁcation as ‘‘integrated’’ HPV using the E2/E6 assay,
while the absence of RNA (fusion product) would lead to classiﬁ-
cation as ‘‘nonintegrated’’ using the APOT assay.
Taken together, the exact frequency of viral integration in CIN
II/III on the basis of PCR and (F)ISH data is open to question.
Comparison of data obtained using several of the DNA integration
methods described above, targeting HPV DNA and RNA in the
same tissue material, is required to answer this ‘‘frequency’’ ques-
tion in CIN II/III. We believe, however, that integrated HPV can
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be detected efﬁciently using the harsh protocol and scoring of
punctate signals. For the identiﬁcation of HPV, and HPV typing,
the mild protocol is beneﬁcial since this protocol detects HPV
RNA and most probably most of the episomal HPV copies.
We conclude that scoring of punctate HPV FISH signals is a
suitable molecular marker for detection of CIN II/III at risk for
progression to invasive carcinoma. Since punctate signal, and by
implication viral integration, correlates strongly with the presence
of invasive carcinoma, the screening of cytological specimens
from high-grade lesions by HPV FISH with determination of the
signal pattern could represent an auxiliary strategy to standard
screening methods. However, the pretreatment procedure used for
ISH is extremely important because episomal copies, as well as
RNA, will produce morphologically localized signals that can be
misinterpreted as integrated virus. The concepts presented in our
study could help to design an optimal procedure and help classiﬁ-
cation of HPV patterns.
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